Practical Concepts to Determine Fair Market Value
Product Description:
AUDIOCONFERENCE ON TAPE OR CD
Sponsored by e-learning compliance courses
presented on May 23, 2007
Protect yourself from regulatory scrutiny and avoid compliance fines.
With an increase in government action and visibility of fair market value (FMV) issues publicly, companies can no longer wait and watch this issue evolve.
“My company has set internal policies to increase compliance in this area. Are we still at risk?”
Yes. Without a standard definition or a universal procedure of determination, you can still end up facing federal prosecution. With so much at stake, don’t take any chances. Listen to this program for the expert guidance you need to accurately set FMV, navigate risk factors, and ensure full compliance.
Take action. Purchase this important audioconference today and listen to Practical concepts to determine fair market value: Strategic approaches for compliance. During this program, Wendy C. Goldstein, JD, MHP, Epstein, Becker & Green, Robert Nauman, BioPharma Advisors Network, and Elio Evangelista, Cutting Edge Information, team up to present strategic approaches you can take to mitigate risks associated with FMV and ensure compliance. They’ll present their perspectives of how pharmaceutical companies can develop a consistent and transparent set of business processes and methodologies to determine and monitor FMV within your own organization.
TAKE A LOOK AT OUR AGENDA
- Concept of Fair Market Value (FMV)
- Legal overview – why do we care?
- What are the relevant relationships?
- How to incorporate FMV considerations into compliance infrastructure
- Written standards
- Monitoring
- Auditing
- FMV from a commercial perspective
- How does FMV get implemented?
- Methodology
- Putting objective criteria in place
- Selecting and managing thought leaders
- Data – research methodology
- Benchmarks
- Hourly rate
- Tiers of leadership
- What are people doing?
A question and answer session follows the presentation.
FEATURED SPEAKERS
Wendy C. Goldstein, JD, MPH, is a member of Epstein, Becker & Green's National Health Law Practice in the New York City office. She is the chairperson of the Pharmaceutical Industry Health Regulatory Practice Group, and is experienced providing health regulatory counsel on fraud and abuse issues associated with pharmaceutical marketing and promotional practices, reimbursement issues, managed care contracting practices, disease management initiatives and manufacturer joint ventures.
Robert Nauman is principal of BioPharma Advisors Network in Cary, NC. He is a former pharmaceutical executive with more than 23 years in the pharmaceutical and life sciences industry, and expertise in solving key business issues and creating organizational change that maximize revenue and minimize cost. His unique talents in commercialization of new products, management of key opinion leaders, and sales/marketing management are supported by his strengths as a team player that leads by example, and follows through on every detail. He is a leader of change recognized by management, customers and many of his peers.
Elio Evangelista is a senior research analyst for Cutting Edge Information in Durham, NC. He is experienced in brand and commercialization support activities, such as thought leader management, market research and competitive intelligence and is the author of several major studies on critical decision-support functions.
WHO SHOULD LISTEN?
- Pharma compliance executives and officers
- Pharma counsel
- Healthcare attorneys
This program is also designed for medical affairs professionals, marketing and sales professionals, pharma consultants, and support vendors.
BONUS MATERIALS INCLUDED IN YOUR MATERIALS PACKET!
In addition to the expertise and advice presented during this audioconference, you'll also receive a slide presentation of the program materials.
Purchase a tape or CD of the program and listen when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.
Product Types : Departments :
